Novocure LtdPhase 3 TRIDENT study failed to meet primary endpoint in glioblastoma.
FreeCast shares surged 170% in premarket trading after the company announced a reseller agreement for Starlink Business services, allowing it to offer enterprise satellite broadband alongside its streaming platform. Accenture tumbled more than 11% after trimming the upper end of its annual revenue growth forecast and announcing cybersecurity acquisitions including a majority stake in Dragos. Pfizer slipped 1.7% on news that CFO Dave Denton will step down in August. Oklo rose 2% after signing a letter of intent with Centrus Energy for high-assay low-enriched uranium supply starting in 2029. Novocure fell 10% after its Phase 3 TRIDENT study failed to meet the primary endpoint of improving overall survival in newly diagnosed glioblastoma.
Novocure LtdPhase 3 TRIDENT study failed to meet primary endpoint in glioblastoma.
Pfizer IncCFO Dave Denton will step down in August.
Oklo Inc.Signed letter of intent with Centrus Energy for HALEU supply starting in 2029.
Centrus Energy Corp.Oklo signed a letter of intent with Centrus for HALEU supply, indicating potential future demand for Centrus's uranium enrichment services.
Accenture plcTrimmed upper end of annual revenue growth forecast and announced cybersecurity acquisitions.
FreeCast, Inc. Class A Common StockFreeCast announced a reseller agreement for Starlink Business services, enabling it to offer enterprise satellite broadband alongside its streaming platform.